Ocular Surface Disease and Glaucoma: How to Evaluate Impact on Quality of Life-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ocular Surface Disease and Glaucoma: How to Evaluate Impact on Quality of Life

Published:2013-05 Issue:4 Volume:29 Page:390-394
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Rossi Gemma Caterina Maria¹,Pasinetti Gian Maria²,Scudeller Luigia³,Bianchi Paolo Emilio¹

Affiliation:

1. University Eye Clinic, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

2. Eye Unit, Istituto Beato Palazzolo, Bergamo, Italy.

3. Clinical Epidemiology and Biometric Unit, Scientific Direction, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2011.0159

Reference19 articles.

1. Prevalence of and Risk Factors for Dry Eye Syndrome

2. Ocular surface inflammatory changes induced by topical antiglaucoma drugs

3. Incidence and Prevalence of Glaucoma in Severe Ocular Surface Disease

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study;Journal of Ocular Pharmacology and Therapeutics;2024-08-16

2. The PRAMOS Study: PRostaglandin Analogues Monotherapy—Awareness Survey on Ocular Surface Involvement;Ophthalmology and Therapy;2024-04-08

3. Alternatives to Topical Glaucoma Medication for Glaucoma Management;Clinical Ophthalmology;2023-12

4. Latanoprost PF vs. Bimatoprost PF: Which Treats the Ocular Surface Better?;Journal of Clinical Medicine;2023-10-25

5. Challenging the "Topical Medications-First” Approach to Glaucoma: A Treatment Paradigm in Evolution;Ophthalmology and Therapy;2023-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3